Page last updated: 2024-08-24

plerixafor and pemetrexed

plerixafor has been researched along with pemetrexed in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Hou, S; Kadoch, O; Li, H; Li, J; Li, S; Li, T; Lin, Q; Xie, L; Xu, Z; Yang, YL	1

Reviews

1 review(s) available for plerixafor and pemetrexed

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for plerixafor and pemetrexed

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2019, Volume: 67, Issue:2 Topics: Animals; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Luminescent Measurements; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice, Inbred BALB C; Mice, Nude; Pemetrexed; Pleural Neoplasms; Protein Isoforms; Receptors, CXCR4; Signal Transduction	2019

Article

Year

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.

Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023

Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2019, Volume: 67, Issue:2

Topics: Animals; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Luminescent Measurements; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice, Inbred BALB C; Mice, Nude; Pemetrexed; Pleural Neoplasms; Protein Isoforms; Receptors, CXCR4; Signal Transduction

2019